Celltrion
068270.KS
#651
Rank
โ‚น3.343 T
Marketcap
โ‚น14,697
Share price
-0.93%
Change (1 day)
28.96%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2026 (TTM): โ‚น117.66 Billion

According to Celltrion 's latest financial reports the company's current earnings are โ‚น3.31 Billion. In 2025 the company made an earning of โ‚น79.83 Billion, an increase over its 2024 earnings that were of โ‚น43.30 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น117.66 B47.37%
2025 โ‚น79.83 B84.38%
2024 โ‚น43.30 B-8.89%
2023 โ‚น47.52 B6.61%
2022 โ‚น44.57 B-21.93%
2021 โ‚น57.09 B10.28%
2020 โ‚น51.77 B65.38%
2019 โ‚น31.30 B16.74%
2018 โ‚น26.81 B-33.93%
2017 โ‚น40.59 B106.65%
2016 โ‚น19.64 B25.18%
2015 โ‚น15.69 B-6.4%
2014 โ‚น16.76 B47.49%
2013 โ‚น11.36 B-33.58%
2012 โ‚น17.11 B
2010 โ‚น8.90 B72.52%
2009 โ‚น5.16 B258.3%
2008 โ‚น1.44 B